Movement Disorders (revue) - Checkpoint (PascalFrancis)

Index « Keywords » - entrée « D1 Dopamine receptor »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Cytotoxicity < D1 Dopamine receptor < D2 Dopamine receptor  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 13.
Ident.Authors (with country if any)Title
002710 (2002) Marie-Paule Muriel [France] ; Gaël Orieux [France] ; Etienne C. Hirsch [France]Levodopa but not ropinirole induces an internalization of D1 dopamine receptors in Parkinsonian rats
002929 (2001) Marie-Paule Muriel [France] ; Yves Agid [France] ; Etienne Hirsch [France]Plasticity of afferent fibers to striatal neurons bearing D1 dopamine receptors in Parkinson's disease
002C10 (2000) Sarah A. Treseder [Royaume-Uni] ; Lance A. Smith [Royaume-Uni] ; Peter Jenner [Royaume-Uni]Endogenous dopaminergic tone and dopamine agonist action
003080 (1998) M. Gassen [Allemagne] ; A. Gross [Israël] ; M. B. H. Youdim [Israël]Apomorphine enantiomers protect cultured pheochromocytoma (PC12) cells from oxidative stress induced by H2O2 and 6-hydroxydopamine
003128 (1997) L. Rioux [États-Unis] ; P. A. Frohna [États-Unis] ; J. N. Joyce [États-Unis] ; J. S. Schneider [États-Unis]The effects of chronic levodopa treatment on pre- and postsynaptic markers of dopaminergic function in striatum of parkinsonian monkeys
003377 (1996) L. V. Metman [États-Unis] ; P. J. Blanchet [États-Unis] ; D. De Jong [États-Unis] ; M. M. Mouradian [États-Unis] ; T. N. Chase [États-Unis]Effect of the putative dopamine D1 agonist and D2 antagonist FCE 23884 on Parkinson's disease
003379 (1996) P. J. Blanchet [Canada] ; R. Grondin ; P. J. BedardDyskinesia and wearing-off following dopamine D1 agonist treatment in drug-naive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned primates
003685 (1993) C. A. Hubbard [États-Unis] ; J. M. TrugmanReversal of reserpine-induced catalepsy by selective D1 and D2 dopamine agonists
003733 (1993) B. Gomez-Mancilla [Canada] ; R. Boucher ; C. Gagnon ; T. Di Paolo ; R. Markstein ; P. J. BedardEffect of adding the D1 agonist CY 208-243 to chronic bromocriptine treatment. I: Evaluation of motor parameters in relation to striatal catecholamine content and dopamine receptors
003818 (1992) M. Emre [Suisse] ; U. K. Rinne ; A. Rascol ; A. Lees ; Yves Agid [France] ; X. LatasteEffects of a selective partial D1 agonist, CY 208-243, in De Novo patients with Parkinson disease
003821 (1992) B. Gomez-Mancilla [Canada] ; R. Boucher ; P. J. BedardEffect of LY 171555 and CY 208-243 on tremor suppression in the MPTP monkey model of Parkinsonism
003A14 (1989) R. F. Pfeiffer ; L. H. Herrera ; C. S. Glaeske ; R. E. HofmanCQP A01-403 in Parkinson's disease: an open-label pilot study
003A18 (1989) J. A. Temlett ; N. P. Quinn ; P. G. Jenner ; C. D. Marsden ; E. Pourcher ; A.-M. Bonnet ; Y. Acid ; R. Markstein ; X. LatasteAntiparkinsonian activity of CY 208-243, a partial D-1 dopamine receptor agonist, in MPTP-treated marmosets and patients with Parkinson's disease

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/KwdEn.i -k "D1 Dopamine receptor" 
HfdIndexSelect -h $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/KwdEn.i  \
                -Sk "D1 Dopamine receptor" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PascalFrancis
   |étape=   Checkpoint
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    D1 Dopamine receptor
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024